# Topical Use of Vancomycin in Reducing Sternal Wound Infection in Cardiac Surgery (SWI Trial)

> **NCT02374853** · PHASE2 · TERMINATED · sponsor: **University of Alberta** · enrollment: 1037 (actual)

## Conditions studied

- INFECTION

## Interventions

- **DRUG:** Vancomycin
- **OTHER:** No Vancomycin

## Key facts

- **NCT ID:** NCT02374853
- **Lead sponsor:** University of Alberta
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2015-03
- **Primary completion:** 2019-04
- **Final completion:** 2019-04
- **Target enrollment:** 1037 (ACTUAL)
- **Why stopped:** the preliminary analysis of study result did not show significant benefit that was anticipate
- **Last updated:** 2022-11-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02374853

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02374853, "Topical Use of Vancomycin in Reducing Sternal Wound Infection in Cardiac Surgery (SWI Trial)". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02374853. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*